Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Cancer Institute is soliciting applications under solicitation RFA-CA-27-005 to establish the Glioblastoma Therapeutics Network. This initiative focuses on developing and testing novel therapies for adult glioblastoma, specifically targeting agents that can effectively cross the blood brain barrier. The program supports a collaborative network of teams to move therapeutic agents from pre-clinical development and investigational new drug studies into early phase clinical trials. Eligible agents include novel compounds or existing drugs repurposed for glioblastoma treatment following preclinical validation. Managed by the National Institutes of Health within the Department of Health and Human Services, this opportunity aims to bridge the gap between late pre-clinical research and Phase 0/1 clinical studies. Successful early-stage trials are intended to transition into later-stage trials using established NCI mechanisms. Interested parties must submit their applications by the deadline of October 1, 2026.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
